Black Diamond Therapeutics (BDTX) Earnings Date, Estimates & Call Transcripts $1.64 -0.05 (-2.96%) Closing price 05/9/2025 04:00 PM EasternExtended Trading$1.67 +0.03 (+1.83%) As of 08:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Black Diamond Therapeutics Earnings Summary Black Diamond Therapeutics released Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.28, which beat analysts' consensus estimates of -$0.31 by $0.03. With a trailing EPS of -$1.27, Black Diamond Therapeutics' earnings are expected to grow next year, from ($1.30) to ($1.22) per share. Latest Q4 Earnings DateMar. 6EstimatedConsensus EPS (Mar. 6) -$0.31 Actual EPS (Mar. 6) -$0.28 Beat By $0.03 Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)Powered by Get Black Diamond Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Black Diamond Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBDTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Black Diamond Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.32$0.92$0.30Q2 20252-$0.33-$0.22-$0.28Q3 20252-$0.33-$0.22-$0.28Q4 20252-$0.34-$0.18-$0.26 FY 2025 8 -$1.32 $0.30 -$0.51 Q1 20261-$0.22-$0.22-$0.22Q2 20261-$0.23-$0.23-$0.23Q3 20261-$0.23-$0.23-$0.23Q4 20261-$0.24-$0.24-$0.24 Black Diamond Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/6/2025Q4 2024-$0.31-$0.28+$0.03-$0.28--11/5/2024--$0.37-$0.28+$0.09-$0.28--8/6/2024Q2 2024-$0.39-$0.36+$0.03-$0.36--5/9/2024Q1 2024-$0.44-$0.35+$0.09-$0.35--3/12/2024Q4 2023-$0.47-$0.34+$0.13-$0.34--11/6/2023Q3 2023-$0.49-$0.45+$0.04-$0.45--8/11/2023Q2 2023-$0.54-$0.52+$0.02-$0.52-- Black Diamond Therapeutics Earnings - Frequently Asked Questions When did Black Diamond Therapeutics announce their last quarterly earnings? Black Diamond Therapeutics (NASDAQ:BDTX) last announced its quarterly earning data on Thursday, March 6, 2025. Learn more on BDTX's earnings history. Did Black Diamond Therapeutics beat their earnings estimates last quarter? In the previous quarter, Black Diamond Therapeutics (NASDAQ:BDTX) reported ($0.28) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.31) by $0.03. Learn more on analysts' earnings estimate vs. BDTX's actual earnings. How much profit does Black Diamond Therapeutics generate each year? Black Diamond Therapeutics (NASDAQ:BDTX) has a recorded net income of -$82.44 million. BDTX has generated -$1.27 earnings per share over the last four quarters. What is Black Diamond Therapeutics's EPS forecast for next year? Black Diamond Therapeutics's earnings are expected to grow from ($1.30) per share to ($1.22) per share in the next year. More Earnings Resources from MarketBeat Related Companies COMPASS Pathways Earnings Results Oruka Therapeutics Earnings Results Aerovate Therapeutics Earnings Results SNDL Earnings Results Allogene Therapeutics Earnings Results Autolus Therapeutics Earnings Results Checkpoint Therapeutics Earnings Results Entrada Therapeutics Earnings Results Benitec Biopharma Earnings Results Solid Biosciences Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Nearly 20 Analysts Raised Meta Price Targets Post-EarningsOXY Stock Rebound Begins Following Solid Earnings BeatMonolithic Power Systems: Will Strong Earnings Spark a Recovery?Datadog Earnings Delight: Q1 Strength and an Upbeat Forecast Upwork's Earnings Beat Fuels Stock Rally—Is Freelancing Booming?DexCom Stock: Earnings Beat and New Market Access Drive Bull CaseDisney Stock Jumps on Earnings—Is the Magic Sustainable? This page (NASDAQ:BDTX) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersSilver’s 332% Surge?Silver has quietly become one of the most promising investments of this cycle. Russia is now stockpiling silve...Lear Capital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Black Diamond Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Black Diamond Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
